February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption (IDE) application to start a U.S.
Ventricular Assist Devices (VAD)
This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.
-
-
DAIC Editor Dave Fornell recently took a tour of the Abiomed Impella production line at its headquarters in Danvers, Mass., just outside of Boston.
-
Interview with Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), director, Acute Mechanical Circulatory Support Program;...
-
Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of The...
News | Artificial Heart | March 10, 2020
March 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total...
News | Heart Failure | March 05, 2020
March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration...
News | Heart Failure | February 12, 2020
February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device...
Gallery | Hemodynamic Support Devices | February 10, 2020 | Dave Fornell, Editor
DAIC Editor Dave Fornell recently took a tour of the Abiomed Impella production line at its headquarters in Danvers...
Videos | Hemodynamic Support Devices | February 07, 2020
Interview with Navin Kapur, M.D., FAHA, FACC,...
Videos | Hemodynamic Support Devices | January 24, 2020
Navin Kapur, M.D., FAHA, FACC, FSCAI, director,...
Videos | Hemodynamic Support Devices | January 09, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, and Melissa...
News | Ventricular Assist Devices (VAD) | January 07, 2020
January 7, 2020 — Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical...
News | Hemodynamic Support Devices | November 04, 2019
November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system...
The new Impella clinical data is detailed in this chart was presented at an October 2019 meeting in Detroit for the management of patients in cardiogenic shock, led by the National Cardiogenic Shock Initiative (NCSI) Study principal investigators.
News | Hemodynamic Support Devices | October 28, 2019
October 28, 2019 — Nearly two years of real-world outcomes data on Abiomed’s Impella RP heart pump shows that when...
Videos | Cardiogenic Shock | October 08, 2019
Technology | Ventricular Assist Devices (VAD) | September 27, 2019
September 27, 2019 — Abiomed’s newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug...
News | Ventricular Assist Devices (VAD) | September 12, 2019
September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its...
